vs
Side-by-side financial comparison of FIRSTSUN CAPITAL BANCORP (FSUN) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $110.0M, roughly 1.4× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs 7.8%, a 11.8% gap on every dollar of revenue. Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 6.9%).
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
FSUN vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.0M | $151.7M |
| Net Profit | $21.6M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 19.6% | 7.8% |
| Revenue YoY | — | -41.1% |
| Net Profit YoY | -8.4% | -80.8% |
| EPS (diluted) | $0.76 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.0M | — | ||
| Q4 25 | $110.2M | $151.7M | ||
| Q3 25 | $107.3M | $267.8M | ||
| Q2 25 | $105.6M | $244.0M | ||
| Q1 25 | $96.2M | $211.8M | ||
| Q4 24 | $98.7M | $257.6M | ||
| Q3 24 | $98.2M | $78.8M | ||
| Q2 24 | $96.2M | $76.1M |
| Q1 26 | $21.6M | — | ||
| Q4 25 | $24.8M | $11.8M | ||
| Q3 25 | $23.2M | $55.4M | ||
| Q2 25 | $26.4M | $-17.7M | ||
| Q1 25 | $23.6M | $21.2M | ||
| Q4 24 | $16.4M | $61.6M | ||
| Q3 24 | $22.4M | $-8.8M | ||
| Q2 24 | $24.6M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | — | — | ||
| Q4 25 | 29.0% | 20.4% | ||
| Q3 25 | 26.4% | 48.7% | ||
| Q2 25 | 31.2% | 13.8% | ||
| Q1 25 | 30.9% | 38.1% | ||
| Q4 24 | 20.4% | 44.4% | ||
| Q3 24 | 29.1% | 12.3% | ||
| Q2 24 | 32.3% | 7.0% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 22.5% | 7.8% | ||
| Q3 25 | 21.6% | 20.7% | ||
| Q2 25 | 25.0% | -7.3% | ||
| Q1 25 | 24.5% | 10.0% | ||
| Q4 24 | 16.6% | 23.9% | ||
| Q3 24 | 22.8% | -11.2% | ||
| Q2 24 | 25.5% | -0.5% |
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.89 | $2.34 | ||
| Q3 25 | $0.82 | $7.76 | ||
| Q2 25 | $0.93 | $-2.95 | ||
| Q1 25 | $0.83 | $3.33 | ||
| Q4 24 | $0.57 | $11.56 | ||
| Q3 24 | $0.79 | $-1.72 | ||
| Q2 24 | $0.88 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $413.7M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $329.4M |
| Total Assets | $8.6B | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $413.7M | — | ||
| Q4 25 | $652.6M | $185.6M | ||
| Q3 25 | $659.9M | $166.0M | ||
| Q2 25 | $785.1M | $96.7M | ||
| Q1 25 | $621.4M | $84.7M | ||
| Q4 24 | $615.9M | $40.6M | ||
| Q3 24 | $573.7M | $46.9M | ||
| Q2 24 | $535.8M | $40.8M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $329.4M | ||
| Q3 25 | $1.1B | $317.2M | ||
| Q2 25 | $1.1B | $235.3M | ||
| Q1 25 | $1.1B | $176.9M | ||
| Q4 24 | $1.0B | $132.4M | ||
| Q3 24 | $1.0B | $60.4M | ||
| Q2 24 | $996.6M | $62.7M |
| Q1 26 | $8.6B | — | ||
| Q4 25 | $8.5B | $918.5M | ||
| Q3 25 | $8.5B | $964.5M | ||
| Q2 25 | $8.4B | $841.0M | ||
| Q1 25 | $8.2B | $761.9M | ||
| Q4 24 | $8.1B | $655.3M | ||
| Q3 24 | $8.1B | $438.5M | ||
| Q2 24 | $8.0B | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $111.5M | $70.4M | ||
| Q3 25 | $49.4M | $99.5M | ||
| Q2 25 | $15.0M | $27.3M | ||
| Q1 25 | $26.4M | $51.0M | ||
| Q4 24 | $101.1M | $54.0K | ||
| Q3 24 | $48.1M | $6.8M | ||
| Q2 24 | $20.9M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $104.0M | $69.0M | ||
| Q3 25 | $47.6M | $99.2M | ||
| Q2 25 | $13.0M | $26.5M | ||
| Q1 25 | $24.3M | $50.9M | ||
| Q4 24 | $95.7M | $-341.0K | ||
| Q3 24 | $47.1M | $6.2M | ||
| Q2 24 | $19.9M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | 94.3% | 45.5% | ||
| Q3 25 | 44.4% | 37.0% | ||
| Q2 25 | 12.3% | 10.9% | ||
| Q1 25 | 25.3% | 24.0% | ||
| Q4 24 | 97.0% | -0.1% | ||
| Q3 24 | 47.9% | 7.8% | ||
| Q2 24 | 20.6% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 0.9% | ||
| Q3 25 | 1.6% | 0.1% | ||
| Q2 25 | 1.9% | 0.3% | ||
| Q1 25 | 2.1% | 0.0% | ||
| Q4 24 | 5.5% | 0.2% | ||
| Q3 24 | 1.1% | 0.8% | ||
| Q2 24 | 1.1% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.49× | 5.95× | ||
| Q3 25 | 2.13× | 1.80× | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 1.12× | 2.40× | ||
| Q4 24 | 6.18× | 0.00× | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 0.85× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
